Infusionstherapie (Basel, Switzerland) 1988-04-01

[Cysteine in parenteral nutrition: comparative study of N-acetyl-cysteine and N,N-diacetylcystine in the rat model].

S Böhler, M Neuhäuser-Berthold, K Wagner, K Virmani, K H Bässler

Index: Infusionstherapie 15(2) , 89-92, (1988)

Full Text: HTML

Abstract

In this study the question of whether N-N-diacetylcystine (DAC), which is more stable than N-acetylcysteine (AcCYS), may provide a useful cysteine source for parenteral nutrition was investigated. In in vitro studies the release of cysteine from DAC was measured. The Michaelis, constant and maximum velocity were compared with the corresponding results for AcCYS. In in vivo studies 3 groups of growing rats were maintained entirely by parenteral nutrition low in methionine for 15 days. Group I (n = 4) received a solution containing AcCYS, and group II (n = 6) was supplied with a corresponding amount of DAC. In the solution given to group III (n = 6) the CYS derivative was replaced by an isonitrogeneous amount of glycine. Utilization of the respective CYS derivatives was judged from weight gain, nitrogen balance, plasma amino acid pattern, and urinary excretion of free amino acids. The results from both the in vitro and in vivo studies indicate that DAC is not a suitable substitute for AcCYS in parenteral nutrition.


Related Compounds

Related Articles:

Influence of N,N'-diacetyl-L-cystine on D-galactosamine/lipopolysaccharide induced immunological liver failure in mice.

2004-10-01

[Yao Xue Xue Bao 39(10) , 782-6, (2004)]

Immunomodulation with DiNAC-- a new approach to the treatment of atherosclerosis?

2002-05-01

[Expert Opin. Investig. Drugs 11(5) , 717-20, (2002)]

The new oral immunomodulating drug DiNAC induces brachial artery vasodilatation at rest and during hyperemia in hypercholesterolemic subjects, likely by a nitric oxide-dependent mechanism.

2008-01-01

[Atherosclerosis 196(1) , 275-82, (2008)]

N,N'-Diacetyl-L-cystine-the disulfide dimer of N-acetylcysteine-is a potent modulator of contact sensitivity/delayed type hypersensitivity reactions in rodents.

1999-03-01

[J. Pharmacol. Exp. Ther. 288(3) , 1174-84, (1999)]

Monitoring of the subtraction process in solid-phase representational difference analysis: characterization of a candidate drug.

2001-06-27

[Gene 271(2) , 183-92, (2001)]

More Articles...